RenaSci

  • Home
  • About
    • About RenaSci
    • Our Experts
    • Scientific Team
    • Facilities
    • Acknowledgements
  • Consultancy
  • Experimental
    • Diabetes
      • Perifused Pancreatic Islets
      • Glucose Tolerance Tests
      • Metabolic Parameters and Biomarkers
      • Genetically-predisposed Animals
      • Insulin Resistance in DIO Animals
      • STZ/HFD Model of Type 2 Diabetes
      • Glucocorticoid-induced Insulin Resistance
      • Histopathology and Immunocytochemistry
    • Obesity
      • Acute Feeding Studies
      • Behavioural Specificity
      • Energy Expenditure
      • Chronic Feeding Studies
      • Pair-feeding Studies
      • High Fat Fed Rats
      • Dietary-induced Obese Animals
      • Genetically-obese Animals
      • Body Composition Analysis
      • Drug-induced Weight Gain
      • Inhibition of Gastric Emptying
      • Lipolysis
    • CNS Techniques
      • Receptor Binding
      • Intracerebral Microdialysis
      • Culex Bambino
      • Neurochemistry
      • Neurochemical Fingerprinting
      • Three Component Test
      • Evaluation of Antipsychotics
      • Behavioural Assays
    • Drug Abuse Testing
      • Drug Discrimination
      • Self-administration
      • Physical Dependence, Tolerance and Sensitisation
      • Other Experimental Options
      • Abuse Liability Testing Collaboration (ALTeC)
  • News
    • Meet Us At
  • Publications
    • Diabetes/Obesity
    • CNS Techniques/Drug Abuse Testing
  • Contact Us
    • Contact Details
    • Enquiry Form
  • Home
  • \
  • About
  • \
  • Facilities
  • About
    • About RenaSci
    • Our Experts
    • Scientific Team
    • Facilities
    • Acknowledgements

Facilities

RenaSci FacilitiesOur offices and state-of the art laboratories and equipment are located in Nottingham, UK.

  • Print this page
  • Bookmark this page

Big enough to cope, small enough to care...

So much more than a CRO, we work with clients from all sectors of the pharmaceutical industry, offering an integrated blend of consultancy and experimental services to help maximise research productivity and streamline drug development in the therapeutic areas of metabolic and CNS disorders.

Want to know more?

For an overview of how our expertise can help solve your problems simply click on the button below to download our latest ebrochure...

© Copyright 2012 RenaSci Ltd

General Links
  • Search
  • Accessibility
  • Terms of Use
  • Print this page
  • Bookmark this page
  • Site Map
  • Contact Us
Consultancy
  • Preclinical Discovery and Development
  • Clinical Development
  • Drug Abuse Evaluation
  • Regulatory Affairs
  • Intellectual Property
  • Strategy and Marketing
Diabetes
  • Perifused Pancreatic Islets
  • Glucose Tolerance Tests
  • Metabolic Parameters and Biomarkers
  • Genetically-predisposed Animals
  • Insulin Resistance in DIO Animals
  • STZ/HFD Model of Type 2 Diabetes
  • Glucocorticoid-induced Insulin Resistance
  • Histopathology and Immunocytochemistry
Obesity
  • Acute Feeding Studies
  • Behavioural Specificity
  • Energy Expenditure
  • Chronic Feeding Studies
  • High Fat Fed Rats
  • Dietary-induced Obese Animals
  • Genetically-obese Animals
  • Body Composition Analysis
  • Inhibition of Gastric Emptying
  • Lipolysis
CNS Techniques
  • Receptor Binding
  • Intracerebral Microdialysis
  • Culex Bambino
  • Neurochemistry
  • Neurochemical Fingerprinting
  • Three Component Test
  • Evaluation of Antipsychotics
  • Other Behavioural Assays
Drug Abuse Testing
  • Drug Discrimination
  • Self-administration
  • Physical Dependence, Tolerance and Sensitisation
  • Other Experimental Options
  • Abuse Liability Testing Collaboration (ALTeC)